2B Determined: The Future of the Serotonin Receptor 2B in Drug Discovery.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
24 08 2023
Historique:
medline: 25 8 2023
pubmed: 16 8 2023
entrez: 16 8 2023
Statut: ppublish

Résumé

The cardiotoxicity associated with

Identifiants

pubmed: 37584406
doi: 10.1021/acs.jmedchem.3c01178
doi:

Substances chimiques

Receptor, Serotonin, 5-HT2B 0
Serotonin 333DO1RDJY
Fenfluramine 2DS058H2CF

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

11027-11039

Subventions

Organisme : NICHD NIH HHS
ID : P50 HD103537
Pays : United States

Auteurs

Aaron M Bender (AM)

Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.

Lauren C Parr (LC)

Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.

William B Livingston (WB)

Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37240, United States.

Craig W Lindsley (CW)

Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37232, United States.
Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee 37232, United States.
Department of Biochemistry, Vanderbilt University, Nashville, Tennessee 37232, United States.

W David Merryman (WD)

Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37240, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH